2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Diseasegraft versus host disease, immune system disorderRecruitingPhase 32025-12-08NCT06682169
Phase I Study of HSK42360 in Solid Tumors With BRAF V600 MutationSolid TumorsRecruitingPhase 12024-08-05NCT06536400